Ohio Administrative Code › Title 3769 - State Racing Commission › Chapter 3769-8 - Drugs; Death of Horse › Section 3769-8-01 - Medication and testing

Current through all regulations passed and filed through July 1, 2024
(A) It
			 is
			 the intent of this rule to protect the integrity of horse racing, guard the
			 health of the horse, and safeguard the interest of the public and racing
			 participants through the prohibition or control of drugs, medications and
			 substances foreign to the natural horse. In this context:
(1) Except for regulatory thresholds of such
			 non-steroidal anti-inflammatory drugs and therapeutic
			 substances authorized for use by order of the commission, and except for
			 those horses eligible for the use of furosemide as permitted by paragraph
			 (A)(1)(b)
			 of this rule, no horse entered to race can carry in its
			 body on race day any prohibited foreign substance.
(a) The presence of any one of the
			 non-steroidal anti-inflammatory drugs approved for use by the commission will
			 be permitted at a concentration not to exceed the respective regulatory
			 threshold established by the commission. Administration of any non-steroidal
			 anti-inflammatory drug is prohibited within the twenty-four hours before post
			 time for the race in which the horse is entered. The presence of more than one
			 of the approved non-steroidal anti-inflammatory drug in serum
			 or plasma is prohibited. The presence of any unapproved non-steroidal
			 anti-inflammatory drug in the post-race serum, plasma, or urine sample is also
			 prohibited. The use of all but one of the approved non-steroidal
			 anti-inflammatory drugs has to be discontinued at least forty-eight hours
			 before the post time for the race in which the horse is entered;
(b) In order to be eligible for furosemide on
			 a raceday, a horse has to be certified as "furosemide eligible" by the
			 state veterinarian, another veterinarian or by the stewards based upon either:
(i) A good cause showing of need for
			 furosemide for said horse by the owner, trainer, veterinarian or authorized
			 agent. For purposes of this rule, prima facie evidence of a "good cause
			 showing" includes but is not
			  limited to the personal observation of
			 the state veterinarian by scope or
			 otherwise, of exercise-induced pulmonary hemorrhage (E.I.P.H.) in the horse;
			 or
(ii) A statement issued in
			 writing by a veterinarian attesting to his personal observation, by scope or
			 otherwise, of E.I.P.H. in the horse; or
(iii) Based upon evidence the horse raced on
			 furosemide in its preceding start, a horse is deemed "furosemide eligible" in
			 writing by the stewards.
(c) A horse eligible for furosemide will be
			 permitted a dose equal to a minimum of one hundred milligrams and a maximum of
			 five hundred milligrams. Horses can
			 only be administered furosemide
			 intravenously four hours or more prior to the post time of its race by a
			 veterinarian who is employed by the owner, authorized agent, or trainer of the horse. Furosemide will only be
			 administered on the grounds of that permit holder. Furosemide may only be
			 administered when an attendant is present. The attendant
			 has to
			 sign documentation indicating they were present during the
			 administration of furosemide.